United States of America known as a pioneer in the Biotechnology industries in the global ranking have a big challenge for 2022. Economic recession symptoms are shining step by step in the US Economy and Federal reserve as a main economic regulator of US do it to control the inflation rate.
Now the big challenge for the US Biotechnology industries is that they should decrease the size and costs for 2022 to stand against US Economic recession.
The thing that in short term is a challenge for the Biotech CEOs to control and monitoring the companies R&D projects and a big challenge for the future high tech products.
Another economic challenge for United States Biotechnology industries is China's Espionage program for copying US High tech biotechnology patents and data.
The thing that make Global competition hard for United States.
The other factor that will impacts US Bio technology corporations is that Political and economical polarization impacts on the chain of Supply and damage strategic nodes for resources and primer material of US Factories and corporations.
The thing that is a big threaten against Continues production in the US.
